Tirzepatide for the treatment of obstructive sleep apnea: from apnea-hypopnea index reduction to cardiometabolic risk mitigation-a narrative review
Multidisciplinary respiratory medicine · 2026 Nov 4 · Mesfin-Bireda S, Hillman Urek K et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 3 19:00 ETSource: Multidisciplinary respiratory medicine
From the source
Read at pubmed.ncbi.nlm.nih.govTirzepatide for the treatment of obstructive sleep apnea: from apnea-hypopnea index reduction to cardiometabolic risk mitigation-a narrative review
Multidisciplinary respiratory medicine · 2026 Nov 4 · Mesfin-Bireda S, Hillman Urek K et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42979856/
